Close

UPDATE: BioMed Realty (BMR) M&A Rumors Alter Value Debate, Says Canaccord Genuity; Rating Upgraded to Buy

September 23, 2015 6:43 AM EDT Send to a Friend
(Updated - September 23, 2015 10:13 AM EDT)

Canaccord Genuity upgraded BioMed Realty (NYSE: BMR) from Hold to Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login